MedTrace Logo

Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants

NCT02935101 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2019-05-23

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether prednisolone lowers intensity and frequency of craving in heroin-addicted subjects undertaking a detoxification of cocaine and/or heroin.

Conditions

  • Opioid Dependence
  • Cocaine Dependence

Interventions

DRUG

Prednisolone

formulated for oral administration. encapsulated.

DRUG

Placebo (for Prednisolone)

Sugar pill manufactured to mimic Prednisolon 10mg capsules

Sponsors & Collaborators

  • Psychiatric Hospital of the University of Basel

    collaborator OTHER

  • Prof. Dominique de Quervain, MD

    lead OTHER

Principal Investigators

  • Antje Kemter, MD · UPK Basel

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02935101 on ClinicalTrials.gov